164 related articles for article (PubMed ID: 27313612)
21. Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery.
Shuai JH; Leng ZF; Wang P; Ji YC
World J Clin Cases; 2023 Sep; 11(27):6407-6414. PubMed ID: 37900235
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
23. High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk.
Zhao H; Li H; Huang T
Biol Trace Elem Res; 2018 Aug; 184(2):317-324. PubMed ID: 29164514
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological characteristics of thyroid nodules and risk factors for malignant nodules: a retrospective study from 6,304 surgical cases.
Huan Q; Wang K; Lou F; Zhang L; Huang Q; Han Y; Sun H; Zhu L; Lin P; Song J; Liu F; Wang Q; Hou W
Chin Med J (Engl); 2014; 127(12):2286-92. PubMed ID: 24931243
[TBL] [Abstract][Full Text] [Related]
25. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy.
Koike E; Noguchi S; Yamashita H; Murakami T; Ohshima A; Kawamoto H; Yamashita H
Arch Surg; 2001 Mar; 136(3):334-7. PubMed ID: 11231857
[TBL] [Abstract][Full Text] [Related]
26. Impact of Hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence.
Gabalec F; Srbova L; Nova M; Hovorkova E; Hornychova H; Jakubikova I; Ryska A; Cap J
Endokrynol Pol; 2016; 67(1):48-53. PubMed ID: 26884115
[TBL] [Abstract][Full Text] [Related]
27. [Association between preoperative serum thyroid-stimulating hormone level and nonfunctioning malignant nodule thyroid disease].
Zeng Q; Liu J; Zhu J; Hu G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1931-3. PubMed ID: 25895308
[TBL] [Abstract][Full Text] [Related]
28. Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
Hosseini S; Payne RJ; Zawawi F; Mlynarek A; Hier MP; Tamilia M; Forest VI
J Otolaryngol Head Neck Surg; 2016 May; 45(1):31. PubMed ID: 27179632
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.
Lin Y; Li T; Liang J; Li X; Qiu L; Wang S; Chen Y; Kang Z; Li F
Clin Nucl Med; 2011 Dec; 36(12):1102-5. PubMed ID: 22064080
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer.
Jo K; Lim DJ
Korean J Intern Med; 2018 Nov; 33(6):1050-1057. PubMed ID: 30396251
[TBL] [Abstract][Full Text] [Related]
32. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
[TBL] [Abstract][Full Text] [Related]
33. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
[TBL] [Abstract][Full Text] [Related]
34. Can vascularity at power Doppler US help predict thyroid malignancy?
Moon HJ; Kwak JY; Kim MJ; Son EJ; Kim EK
Radiology; 2010 Apr; 255(1):260-9. PubMed ID: 20308462
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of serum midkine as a biomarker in differentiated thyroid cancer.
Meng Z; Tan J; Zhang G; Tian W; Fu Q; Li W; He X; Wu S; Yang Z; Liang X; Dong L; Zhang Q; Liu L; Zhang Y; Xu K; Liu B; Li N; Li X; Jia Q; He Y; Wang S; Wang R; Zheng W; Song X; Zhang J; Hu T; Liu N; Upadhyaya A
Life Sci; 2015 Jun; 130():18-24. PubMed ID: 25817231
[TBL] [Abstract][Full Text] [Related]
36. Serum thyroglobulin adds no additional value to ultrasonographic features in a thyroid malignancy.
Youn I; Sung JM; Kim EK; Kwak JY
Ultrasound Q; 2014 Dec; 30(4):287-90. PubMed ID: 25415866
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of the nomogram based on ultrasound, thyroid stimulating hormone, and inflammatory marker in papillary thyroid carcinoma: a case-control study.
Tang ZW; Li XX; Luo J
Transl Cancer Res; 2023 Mar; 12(3):490-501. PubMed ID: 37033338
[TBL] [Abstract][Full Text] [Related]
38. [Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules].
Lü ZH; Zhu HQ; Dou JT; Luo YK; Kong QL; Yang GQ; Ba JM; Mu YM; Lu JM
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(46):3272-5. PubMed ID: 21223785
[TBL] [Abstract][Full Text] [Related]
39. Relationship between Variation of Pre-ablation Stimulated Thyroglobulin and Distant Metastasis in Patients with Differentiated Thyroid Cancer.
Zhao T; Liang J; Li TJ; Li CX; Hui C; Yang K; Li F; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Jun; 37(3):315-9. PubMed ID: 26149144
[TBL] [Abstract][Full Text] [Related]
40. Referrals for Elevated Thyroid Stimulating Hormone to Pediatric Endocrinologists.
Gammons S; Presley BK; White PC
J Endocr Soc; 2019 Nov; 3(11):2032-2040. PubMed ID: 31637344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
